Correction: Molecular Medicine 31, 203 (2025)
https://doi.org/10.1186/s10020-025-01260-z
In the sentence beginning ‘More notably, the strong link between …. disease (Satarker et al. 2021).’ the term “SARS-CoV-2” is written as “SARS-Cov-2” in the section Tyrosine kinases in viral entry and replication of this article [1].
The corrected sentence should read as "More notably, the strong link between ACE2 & JAK-STAT signaling throughout the COVID-19 disease analysis was directly demonstrated by the above relationship involving ACE2 & IFN-JAK-STAT signaling being confirmed in a separate cell related to SARS-Cov and SARS-CoV-2 disease (Satarker et al. 2021)."
The original article has been corrected.
Contributor Information
Narendra Kumar, Email: narendra08@tamu.edu.
Jayshree Mishra, Email: Jayshree.mishra@tamu.edu.
References
- 1.Kumar N, Segovia D, Kumar P, et al. Mucosal implications of oral Jak3-targeted drugs in COVID patients. Mol Med. 2025;31:203. 10.1186/s10020-025-01260-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
